ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 나노항체 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 15억 5,000만 달러에서 2025년에는 18억 달러로, CAGR 16.4%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 만성 질환 및 감염증 증가, 나노바디 기반 진단 도구의 보급 확대, 생명공학 및 생명과학 분야에서의 연구 자금 증가, 암 면역요법 연구에서 나노바디의 이용 확대, 나노항체의 이점에 대한 인식 증가로 이어졌습니다.
나노항체 시장 규모는 향후 수년간 급속한 성장이 예상되고 있습니다. 2029년까지 32억 7,000만 달러에 달하고, CAGR은 16.0%가 될 전망입니다. 예측 기간의 성장은 정밀의료 및 맞춤형 의료에 대한 수요 증가, 표적 약물 전달 시스템에 대한 관심 증가, 나노바디 기반 요법의 임상시험 증가, 나노바디 기반 조영제의 채용 확대, 나노항체 제품의 상업화 진전에 의해 견인될 전망입니다. 예측기간의 주요 동향으로는 나노항체의 신규 치료 응용 개발, 나노입자 약물전달 시스템과의 통합, 다중화 나노항체 스크리닝 기술의 혁신, 신속한 항체 검출을 위한 바이오센서 기술 도입, POC(Point of Care) 진단 기기에 대한 나노항체 통합 등을 들 수 있습니다.
맞춤형 의료에 대한 수요 증가가 향후 나노항체 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전자 구성, 생활 습관, 환경에 맞게 조정된 치료법으로 각 환자에게 가장 효과적인 치료를 보장합니다. 만성 및 희귀질환의 유병률 증가는 이러한 수요를 뒷받침하고 있으며, 이러한 질환은 종종 표적화된 환자 고유의 치료 접근법을 필요로 합니다. 나노항체는 개별 환자 프로파일 및 질병 메커니즘을 따르는 고도로 특이적이고 맞춤화 가능한 표적 솔루션을 제공함으로써 맞춤형 의료를 지원합니다. 예를 들어 2024년 2월 미국 비영리단체 '맞춤형 의료연합'이 발표한 바에 따르면 2023년 FDA가 희소질환 환자용 신규맞춤형 치료를 16건 승인하고 2022년 6건에서 증가했습니다. 따라서 맞춤형 의료에 대한 수요 증가가 나노항체 시장의 확대를 견인하고 있습니다.
나노항체 시장의 기업은 질병 표적화와 치료 효과를 높이기 위해 완전 다특이성 나노바디를 포함한 첨단 치료제의 개발에 주력하고 있습니다. 완전 다특이성 치료제는 2개 이상의 표적 분자에 동시에 결합할 수 있는 생물학적 제제로, 복잡한 질환에 보다 정밀하고 효과적인 개입을 가능하게 합니다. 예를 들어, 2023년 2월에는 중국 바이오의약품 기업인 Biocytogen Pharmaceuticals (Beijing) Co., Ltd.가 100개 이상의 표적에 대한 완전 인간형 나노바디 치료제를 개발하는 'Nano 100 Project'를 시작했습니다. 이 회사의 독자적인 기술인 RenNan 마우스 플랫폼을 활용하여 인간화 공정 없이 완전 인간형 나노바디를 생산합니다. 이 프로젝트는 높은 처리량의 생체 외 및 생체 내 스크리닝 기술을 결합하여 표적 적용 범위를 확대하고 나노바디 의약품을 가속화하는 것을 목표로 합니다. 이러한 나노바디는 우수한 조직 투과성, 안정성 및 설계 유연성을 보여주며 세포 요법, 이중특이적 항체, 항체 약물 복합체(ADC), 방사성 핵종 항체 복합체 등의 양식에 적합합니다. 궁극적으로 Nano 100 Project는 암, 면역 질환 및 신경 질환에 대한 새로운 치료제의 개발을 효율화합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 나노항체 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 나노항체 시장 : 성장률 분석
세계의 나노항체 시장 실적 : 규모와 성장, 2019-2024년
세계의 나노항체 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 나노항체 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 나노항체 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
싱글 도메인 항체
중쇄 항체
재조합 나노항체
결합 나노항체
이중특이성 및 다특이성 나노항체
세계의 나노항체 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
파지 디스플레이 기술
재조합 DNA 기술
분자 클로닝
세계의 나노항체 시장 : 원료별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
동물 유래
재조합
식물 유래
세계의 나노항체 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
생체외 질환 검출
비침습적 생체내 진단
종양 표적 요법
신경계 질환
순환기 질환
감염증
기타 용도
세계의 나노항체 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제약기업
바이오테크놀러지 기업
학술연구기관
병원 및 진단실험실
세계의 나노항체 시장 : 싱글 도메인 항체 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
인간 단일 도메인 항체
낙타과 단일 도메인 항체
합성 싱글 도메인 항체
상어 유래 단일 도메인 항체
세계의 나노항체 시장 : 중쇄 항체 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
낙타과 동물 중쇄 항체
상어 중쇄 항체
엔지니어드 중쇄 항체
키메라 중쇄 항체
세계의 나노항체 시장 : 재조합 나노항체 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세균 발현 나노항체
효모 발현 나노항체
포유류 발현 나노항체
무세포 발현 나노항체
세계의 나노항체 시장 : 결합 나노항체 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
약물 결합 나노항체
형광 결합 나노항체
효소 결합 나노항체
방사성 나노항체
세계의 나노항체 시장 : 이중특이성 및 다특이성 나노항체 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
이중 표적 나노항체
삼특이성 나노항체
4가 나노항체
다기능 나노항체
제7장 지역별/국가별 분석
세계의 나노항체 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 나노항체 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
나노항체 시장 : 경쟁 구도
나노항체 시장 : 기업 프로파일
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Rad Laboratories Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bio-Techne Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Innovent Biologics Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
GenScript Biotech Corporation
Biocytogen Pharmaceuticals Co. Ltd.
Beroni Group Limited.
Cusabio Technology LLC
Harbour BioMed Co. Ltd.
MoonLake Immunotherapeutics Co. Ltd.
Alphamab Oncology Co. Ltd.
Santa Cruz Biotechnology Inc.
Rockland Immunochemicals Inc.
Creative Biolabs Inc.
Promab Biotechnologies Inc.
ExeVir Bio NV
Isogenica Ltd.
Allele Biotechnology And Pharmaceuticals Inc.
Gulliver Biomed Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
나노항체 시장(2029년) : 새로운 기회를 제공하는 국가
나노항체 시장(2029년) : 새로운 기회를 제공하는 부문
나노항체 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Nano antibodies, also known as single-domain antibodies or nanobodies, are small antibody fragments derived from the unique heavy-chain antibodies found in camelids. They maintain the full antigen-binding capability of conventional antibodies but offer greater stability, are easier to produce, and can bind to hidden or hard-to-access epitopes.
The primary products of nano antibodies include single-domain antibodies, heavy-chain antibodies, recombinant nano antibodies, conjugated nano antibodies, and bispecific and multispecific nano antibodies. Single-domain antibodies are small, stable antibody fragments derived from heavy-chain-only antibodies that retain full antigen-binding capacity and are used for therapeutic, diagnostic, and research purposes. They are developed using various technologies, such as phage display technology, recombinant deoxyribonucleic acid (DNA) technology, and molecular cloning, and originate from sources such as animal-derived, recombinant, and plant-derived systems. These antibodies are applied across a wide range of uses, including in vitro disease detection, non-invasive in vivo diagnosis, tumor-targeted therapy, nervous system diseases, circulatory diseases, infectious diseases, and more, and serve end users such as pharmaceutical companies, biotechnology firms, academic and research institutions, and hospitals and diagnostic laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The nano antibodies market research report is one of a series of new reports from The Business Research Company that provides nano antibodies market statistics, including nano antibodies industry global market size, regional shares, competitors with a nano antibodies market share, detailed nano antibodies market segments, market trends and opportunities, and any further data you may need to thrive in the nano antibodies industry. This nano antibodies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nano antibodies market size has grown rapidly in recent years. It will grow from $1.55 billion in 2024 to $1.80 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period resulted from the increasing prevalence of chronic and infectious diseases, growing adoption of nanobody-based diagnostic tools, rising research funding in biotechnology and life sciences, expanding use of nanobodies in cancer immunotherapy research, and greater awareness of the advantages of nanoantibodies.
The nano antibodies market size is expected to see rapid growth in the next few years. It will grow to $3.27 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period will be driven by rising demand for precision and personalized medicine, a growing focus on targeted drug delivery systems, an increasing number of clinical trials for nanobody-based therapies, expanding adoption of nanobody-based imaging agents, and growing commercialization of nanoantibody products. Major trends in the forecast period include the development of novel therapeutic applications of nano antibodies, integration of nano antibodies with nanoparticle drug delivery systems, innovations in multiplexed nano antibody screening technologies, incorporation of biosensor technologies for rapid antibody detection, and the integration of nano antibodies into point-of-care diagnostic devices.
The increasing demand for personalized medicines is expected to drive the growth of the nano antibodies market going forward. Personalized medicines are treatments tailored to an individual's genetic makeup, lifestyle, and environment, ensuring the most effective therapy for each patient. The rising prevalence of chronic and rare diseases is fueling this demand, as these conditions often require targeted, patient-specific therapeutic approaches. Nano antibodies support personalized medicine by providing highly specific, customizable, and targeted solutions aligned with individual patient profiles and disease mechanisms. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six approvals in 2022. Therefore, the growing demand for personalized medicines is driving the expansion of the nano antibodies market.
Companies in the nano antibodies market are focusing on developing advanced therapeutics, including fully multispecific nanobodies, to enhance disease targeting and treatment efficacy. Fully multispecific therapeutics are biologics capable of simultaneously binding to two or more targets, enabling more precise and effective interventions for complex diseases. For example, in February 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a China-based biopharmaceutical company, launched the Nano 100 Project to develop fully human nanobody therapeutics against over 100 targets. Using Biocytogen's proprietary RenNan mouse platform, the initiative generates fully human nanobodies without requiring humanization. By combining high-throughput in vitro and in vivo screening technologies, the project aims to accelerate target coverage and nanobody drug discovery. These nanobodies demonstrate strong tissue penetration, stability, and engineering flexibility, making them suitable for modalities such as cell therapies, bispecific antibodies, antibody-drug conjugates (ADCs), and radionuclide antibody conjugates. Ultimately, the Nano 100 Project streamlines the development of novel therapeutics for cancer, immune disorders, and neurological diseases.
In September 2024, Valerion Therapeutics LLC, a France-based biotechnology company, acquired Emglev Therapeutics for an undisclosed amount. This acquisition aimed to enhance Valerion's technological capabilities in antibody therapeutics and accelerate its expansion into next-generation immunotherapies. Emglev Therapeutics specializes in single-domain antibodies (sdAbs), also known as nanobodies, further strengthening Valerion's pipeline in advanced antibody-based therapeutics.
Major companies operating in the nano antibodies market are Sanofi S.A., AstraZeneca plc, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Innovent Biologics Inc., GenScript Biotech Corporation, Biocytogen Pharmaceuticals Co. Ltd., Beroni Group Limited., Cusabio Technology LLC, Harbour BioMed Co. Ltd., MoonLake Immunotherapeutics Co. Ltd., Alphamab Oncology Co. Ltd., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Promab Biotechnologies Inc., ExeVir Bio N.V., Isogenica Ltd., Allele Biotechnology And Pharmaceuticals Inc., Gulliver Biomed Inc., Capralogics Inc.
North America was the largest region in the nano antibodies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nano antibodies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nano antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nano antibodies market consists of sales of nano antibody constructs, diagnostic reagents, therapeutic formulations, assay kits, and research-grade antibody products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nano Antibodies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nano antibodies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nano antibodies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nano antibodies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Single-Domain Antibodies; Heavy-Chain Antibodies; Recombinant Nano Antibodies; Conjugated Nano Antibodies; Bispecific And Multispecific Nano Antibodies
3) By Source: Animal-Derived; Recombinant; Plant-Derived
4) By Application: Disease Detection In Vitro; Non-Invasive Diagnosis In Vivo; Tumor Targeted Therapy; Nervous System Disease; Circulatory Disease; Infectious Disease; Other Applications
5) By End-User: Pharmaceutical Companies; Biotechnology Firms; Academic And Research Institutions; Hospitals And Diagnostic Laboratories
Subsegments:
1) By Single-Domain Antibodies: Human Single-Domain Antibodies; Camelid Single-Domain Antibodies; Synthetic Single-Domain Antibodies; Shark-Derived Single-Domain Antibodies
4. Nano Antibodies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Nano Antibodies Growth Analysis And Strategic Analysis Framework
5.1. Global Nano Antibodies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nano Antibodies Market Growth Rate Analysis
5.4. Global Nano Antibodies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nano Antibodies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nano Antibodies Total Addressable Market (TAM)
6. Nano Antibodies Market Segmentation
6.1. Global Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Domain Antibodies
Heavy-Chain Antibodies
Recombinant Nano Antibodies
Conjugated Nano Antibodies
Bispecific And Multispecific Nano Antibodies
6.2. Global Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.3. Global Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Animal-Derived
Recombinant
Plant-Derived
6.4. Global Nano Antibodies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disease Detection In Vitro
Non-Invasive Diagnosis In Vivo
Tumor Targeted Therapy
Nervous System Disease
Circulatory Disease
Infectious Disease
Other Applications
6.5. Global Nano Antibodies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical Companies
Biotechnology Firms
Academic And Research Institutions
Hospitals And Diagnostic Laboratories
6.6. Global Nano Antibodies Market, Sub-Segmentation Of Single-Domain Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Single-Domain Antibodies
Camelid Single-Domain Antibodies
Synthetic Single-Domain Antibodies
Shark-Derived Single-Domain Antibodies
6.7. Global Nano Antibodies Market, Sub-Segmentation Of Heavy-Chain Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Camelid Heavy-Chain Antibodies
Shark Heavy-Chain Antibodies
Engineered Heavy-Chain Antibodies
Chimeric Heavy-Chain Antibodies
6.8. Global Nano Antibodies Market, Sub-Segmentation Of Recombinant Nano Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial Expression Nano Antibodies
Yeast Expression Nano Antibodies
Mammalian Expression Nano Antibodies
Cell-Free Expression Nano Antibodies
6.9. Global Nano Antibodies Market, Sub-Segmentation Of Conjugated Nano Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Conjugated Nano Antibodies
Fluorescent-Conjugated Nano Antibodies
Enzyme-Conjugated Nano Antibodies
Radiolabeled Nano Antibodies
6.10. Global Nano Antibodies Market, Sub-Segmentation Of Bispecific And Multispecific Nano Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dual-Target Nano Antibodies
Tri-Specific Nano Antibodies
Tetravalent Nano Antibodies
Multifunctional Nano Antibodies
7. Nano Antibodies Market Regional And Country Analysis
7.1. Global Nano Antibodies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nano Antibodies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Nano Antibodies Market
8.1. Asia-Pacific Nano Antibodies Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nano Antibodies Market
9.1. China Nano Antibodies Market Overview
9.2. China Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nano Antibodies Market
10.1. India Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nano Antibodies Market
11.1. Japan Nano Antibodies Market Overview
11.2. Japan Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nano Antibodies Market
12.1. Australia Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nano Antibodies Market
13.1. Indonesia Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nano Antibodies Market
14.1. South Korea Nano Antibodies Market Overview
14.2. South Korea Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nano Antibodies Market
15.1. Western Europe Nano Antibodies Market Overview
15.2. Western Europe Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nano Antibodies Market
16.1. UK Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nano Antibodies Market
17.1. Germany Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nano Antibodies Market
18.1. France Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nano Antibodies Market
19.1. Italy Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nano Antibodies Market
20.1. Spain Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nano Antibodies Market
21.1. Eastern Europe Nano Antibodies Market Overview
21.2. Eastern Europe Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nano Antibodies Market
22.1. Russia Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nano Antibodies Market
23.1. North America Nano Antibodies Market Overview
23.2. North America Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nano Antibodies Market
24.1. USA Nano Antibodies Market Overview
24.2. USA Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Nano Antibodies Market
25.1. Canada Nano Antibodies Market Overview
25.2. Canada Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Nano Antibodies Market
26.1. South America Nano Antibodies Market Overview
26.2. South America Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Nano Antibodies Market
27.1. Brazil Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Nano Antibodies Market
28.1. Middle East Nano Antibodies Market Overview
28.2. Middle East Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Nano Antibodies Market
29.1. Africa Nano Antibodies Market Overview
29.2. Africa Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Nano Antibodies Market Competitive Landscape And Company Profiles
